Dolutegravir

Dolutegravir is an antiretroviral medication used in the treatment of HIV, a virus that attacks the immune system. It belongs to a class of drugs called integrase strand transfer inhibitors (INSTIs), which work by inhibiting the enzyme integrase, a crucial component in the replication of the HIV virus.
The primary use of dolutegravir is to manage HIV infection in adults and adolescents aged 12 years and older, in combination with other antiretroviral medications. It is designed to control the virus, reduce viral load, and improve the immune system’s function. By lowering the viral load, dolutegravir helps prevent the progression of HIV to more severe stages, such as AIDS.
Dolutegravir comes in various forms, including tablets and oral granules. It can be taken with or without food and is usually taken once daily. It is important to follow the prescribed dosage and schedule, as well as the overall treatment plan, to achieve optimal results.
While dolutegravir is an effective medication, it is not a cure for HIV. Therefore, individuals taking this medication must continue the treatment lifelong to maintain control over the virus. Regular monitoring by healthcare professionals is necessary to ensure the effectiveness of the treatment and to identify any potential side effects or drug interactions.